4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Denka Company Limited (4061) operates in the Chemicals industry and is headquartered in Chuo, Japan with about 6,454 employees. Its market capitalization is roughly JPY 295 billion. In the fiscal year ended 2026-03-31, 4061 reported JPY 384.2B in revenue and JPY 15.7B in net income.
Denka Company Limited manufactures and sells organic and inorganic, electronic material, pharmaceutical, and resin-related products in Japan, Asia, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | JPY 384.2B | JPY 400.3B | JPY 389.3B | JPY 407.6B |
| Gross Profit | JPY 94.3B | JPY 84.6B | JPY 82.5B | JPY 102.3B |
| Operating Income (EBIT) | JPY 26.2B | JPY 14.4B | JPY 13.4B | JPY 32.3B |
| Net Income | JPY 15.7B | (JPY 12.3B) | JPY 11.9B | JPY 12.8B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Dividends Paid | (JPY 8.6B) | (JPY 7.8B) | (JPY 7.8B) | (JPY 12.5B) |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets | JPY 681.0B | JPY 655.5B | JPY 616.2B | JPY 592.2B |
| Total Liabilities | JPY 342.2B | JPY 347.2B | JPY 299.3B | JPY 291.8B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4061 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms